{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgKP2oZIKDA","type":"Investor","logokey":"$XxQiFrU4R30LKDcmXaXZVedqfornovhC31j8y0EG4TthCyoN21hBrd","name":"FutuRx","subtype":"Incubator","lastupdate":"2022-10-25T00:00:00.000Z","update_date":"2022-10-25T00:00:00.000Z","lastModified":"Sep 16, 2024","active":1,"confidence_score":56,"confidence_score_reason":"product stage, sector, number of employees, business model, tag line, video or image, markets, not claimed","urlname":"futurx","minimal_profile":null,"hide_reason":null,"status":"Active","fullstatus":"Active","hide_reason_data":null,"acquired":0,"description_edited":0,"tag_line_edited":0,"isisraeli":1,"country":"Israel","formernames":[],"min_date_investments":"2015-01-01T00:00:00.000Z","hide_reasons":[{"id":"71DetFrndkNwNZufhli91PBqJkgDvyWv0skK3yYHYitL6RnFpb2Uf1","reason":"Pending approval - External entity"},{"id":"bMlvNZGgO393OpCQn2LLGyGQIyzd4aZiwm516IvRMWEx6Fkam4LPsQ","reason":"Firm does not match any of Finder’s investors entities"},{"id":"hUspihf43qDmsZbgaEhZKEfAAW3v31Vgv8cpxJzOvLRPPTJ0F4MHzR","reason":"Pending approval"},{"id":"o9Wzo8oG7DIeZVpiC2CdK6IVPWAA4wFvEE97ITVY0oHo6HyeP4v2YV","reason":"Firm asked to delete"},{"id":"rW7l4bkGn6inVBM54t8wGMz9mlLAxGGZOgTQSofPoEagmlofSfwSil","reason":"Foreign, no presence - no Israeli investments/fund"},{"id":"TW4W1IZcqaOGz6jCahuX2wE03SdSzw54lheysaeW0zOAsmOGBFF014","reason":"Foreign, no presence - not enough investments"},{"id":"wcXeLKSl465vLdJtWXjddE1UVQbANeL8NjdsDpAh0CYTtOJw8wHP97","reason":"Firm asked to hide in the meantime"}],"registrar":"514904440","founded_year":2014,"iia_supported":1,"currently_iia_supported":0,"alternativenames":["future x","futur x","Futurex"],"managedassets":"Undisclosed","representing":null,"supported_by":"","supported_by_id":"","inisraelsince":"","inisraelsincemonth":"","investment_lower_amount":null,"investment_upper_amount":null,"marketcapital":null,"marketcapitaldate":null,"oneliner":"","website":"http://www.futurx.co.il/","sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/28173788","instagram":""},"social":["https://www.linkedin.com/company/28173788"],"flattenedsociallinks":"https://www.linkedin.com/company/28173788","apps":{"appstore":"","googleplay":""},"investmentstage":["A Round","Seed","Pre-Seed"],"about":"FutuRx was founded by Johnson & Johnson Innovation – JJDC, Takeda Pharmaceutical Company, through its venture group Takeda Ventures Inc.-TVI and OrbiMed Israel Partners together with the Israeli Innovation Authority of the Ministry of Economy and later joined by Leaps by Bayer, the impact investments unit of Bayer AG.\n\nThe FutuRx incubator is dedicated to the inception of early-stage biopharma ventures based on cutting edge science and supporting them in successful drug development\n\nFutuRx strives to be a catalyst for drug development by bridging the gap between concept and proof of concept through its dedicated system and structure. FutuRx's management, together with its founders, will establish and fully support companies via its in-house laboratory and management facility.\n\nFutuRx provides a unique model for supporting early-stage innovation, by combining expertise of FutuRx management team, and global capabilities of the founders, teamed with the Technological Incubators Program at the Israeli Innovation Authority.\n\nCompanies established by FutuRx benefit from professional assistance by industry leading experts. These global capabilities facilitate the development of innovative technologies, on the way to safely turning them into cutting-edge products for the benefit of patients and healthcare providers.","founded":"1/2014","education":null,"additional_activities":null,"events":null,"techcommunityinvolvement":null,"exits":[{"date":"Oct 2024","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"4rKxIkt5yzd2zEMOOxnocer2uw2GylB4os1ySXJ6al6ba3nXaWubwA","mnatype":"Acquisition","eventtype":"MNAEvent","valuation":"Undisclosed","wasacquired":1,"capitalraised":"Undisclosed","stockexchange":null,"eventvisibility":"Public","token_visibility":"","acquiredcompany_mna":"ImmPACT Bio","acquiredcompany_spac":null,"acquiringcompany_mna":"Lyell Immunopharma","stockexchange_logokey":null,"acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPH9tMALDA","acquiredcompany_reverse":null,"acquiredcompany_spac_id":null,"acquiringcompany_mna_id":"6W86QKe40FccULsEmKiz54HcTvvVHT3EY44IRgbILOpwV4wz5EAvPo","acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":null,"acquiredcompany_mna_fullurl":"/company_page/immpact-bio","acquiredcompany_mna_logokey":"$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","acquiredcompany_mna_urlname":"immpact-bio","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":1,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":"/mnc_page/lyell-immunopharma","acquiringcompany_mna_logokey":"$rSWeI6Y00ziAGrFGd6Y3S49F0XKjSAT35P3PgYtxcB18CtHLjm98aV.png","acquiringcompany_mna_urlname":"lyell-immunopharma","acquiredcompany_reverse_hidden":null,"acquiredcompany_reverse_fullurl":null,"acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":null,"blurFinancialData":"","stockexchange_logourl":"/assets/empty-state.svg","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$rSWeI6Y00ziAGrFGd6Y3S49F0XKjSAT35P3PgYtxcB18CtHLjm98aV.png","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","acquiringcompany_style":"","acquiringcompany_hiddenCompanyTooltip":"","style":"","hiddenCompanyTooltip":""},{"date":"Nov 2019","batch":null,"token":null,"amount":"Undisclosed","isexit":1,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODanOzdCgw","mnatype":null,"eventtype":"ReverseMergerEvent","valuation":"Undisclosed","wasacquired":null,"capitalraised":"Undisclosed","stockexchange":"NYSE","eventvisibility":"Public","token_visibility":"","acquiredcompany_mna":"BiomX","acquiredcompany_spac":null,"acquiringcompany_mna":null,"stockexchange_logokey":"$gCUzHIIl5WdaUySSBVfr4ukCJPjuwKJMFXjiY09JCLUNERZRom14T0","acquiredcompany_mna_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLfx744KDA","acquiredcompany_reverse":"Chardan Healthcare Acquisition Corp","acquiredcompany_spac_id":null,"acquiringcompany_mna_id":null,"acquiredcompany_mna_hidden":0,"acquiredcompany_reverse_id":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCq_MHSCww","acquiredcompany_mna_fullurl":"/company_page/mbcure","acquiredcompany_mna_logokey":"$HdbYudOBbsqnaiwKQswzUrkLLKVKTiKxHZ8NwUkSmdDf9iGxWcCNTl","acquiredcompany_mna_urlname":"mbcure","acquiredcompany_spac_hidden":null,"acquiringcompany_mna_hidden":null,"acquiredcompany_spac_fullurl":null,"acquiredcompany_spac_logokey":null,"acquiredcompany_spac_urlname":null,"acquiringcompany_mna_fullurl":null,"acquiringcompany_mna_logokey":null,"acquiringcompany_mna_urlname":null,"acquiredcompany_reverse_hidden":1,"acquiredcompany_reverse_fullurl":"/company_page/chardan-healthcare-acquisition-corp","acquiredcompany_reverse_logokey":null,"acquiredcompany_reverse_urlname":"chardan-healthcare-acquisition-corp","blurFinancialData":"","stockexchange_logourl":"https://storage.googleapis.com/clean-finder-353810/$gCUzHIIl5WdaUySSBVfr4ukCJPjuwKJMFXjiY09JCLUNERZRom14T0","acquiredcompany_mna_logourl":"https://storage.googleapis.com/clean-finder-353810/$HdbYudOBbsqnaiwKQswzUrkLLKVKTiKxHZ8NwUkSmdDf9iGxWcCNTl","acquiredcompany_spac_logourl":"/assets/empty-state.svg","acquiringcompany_mna_logourl":"/assets/empty-state.svg","acquiredcompany_reverse_logourl":"/assets/empty-state.svg","style":"","hiddenCompanyTooltip":""}],"funds":[],"portfolio":[{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NPYqOgKDA","name":"A2i Therapeutics","hidden":false,"raised":"undisclosed","founded":"2020","fullurl":"/company_page/a2i-therapeutics","logokey":"$0K5XoGaROr8DhBGwnNwsFMah69flclMsHMwteKb7FvfSTjSDdS1zL6","urlname":"a2i-therapeutics","employees":"1-10","description":"Novel Small-molecule Immuno-oncology Agents","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$0K5XoGaROr8DhBGwnNwsFMah69flclMsHMwteKb7FvfSTjSDdS1zL6","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLfx744KDA","name":"BiomX","hidden":false,"raised":"$143.5M","founded":"2015","fullurl":"/company_page/mbcure","logokey":"$HdbYudOBbsqnaiwKQswzUrkLLKVKTiKxHZ8NwUkSmdDf9iGxWcCNTl","urlname":"mbcure","employees":"51-200","description":"Microbiome Therapies for Chronic Diseases","fundingstage":"Public","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":143500000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$HdbYudOBbsqnaiwKQswzUrkLLKVKTiKxHZ8NwUkSmdDf9iGxWcCNTl","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJ2LioYKDA","name":"Bsense Bio Therapeutics","hidden":false,"raised":"$2.7M","founded":"2018","fullurl":"/company_page/bsense-bio-therapeutics","logokey":"$dOA6SUmJ7D9W3bQfbCYcVFJHbmrHRWX98ITS6MJvD3MF0vJXXqlzdW","urlname":"bsense-bio-therapeutics","employees":"1-10","description":"Neuropathic Pain Treatment","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":2700000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$dOA6SUmJ7D9W3bQfbCYcVFJHbmrHRWX98ITS6MJvD3MF0vJXXqlzdW","style":"","hiddenCompanyTooltip":""},{"id":"emKJyaS3AEzL2oByNresmGZiMiqXwcRSN8QcXjNo4GtFtWO0Kjrg5r","name":"CatchMe Theraputics","hidden":false,"raised":"undisclosed","founded":"2021","fullurl":"/company_page/catchme-theraputics","logokey":"$jtt828Tyc5cy5glT1RAP5Ty1mrDWEU8ue7jZIv3y8YQulFynCojskt","urlname":"catchme-theraputics","employees":"1-10","description":"Precision Medicine for Epitranscriptome Machinery","fundingstage":"Pre-Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$jtt828Tyc5cy5glT1RAP5Ty1mrDWEU8ue7jZIv3y8YQulFynCojskt","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JnHu9sJDA","name":"Circuit-Bio","hidden":false,"raised":"undisclosed","founded":"2020","fullurl":"/company_page/circuit-bio","logokey":"$Bgf04dUNhbmDqfwW9yz4f8RrVu5Rbq4o3o8uY4ywGEPW1MSWP2uufl","urlname":"circuit-bio","employees":"1-10","description":"Platform of Logical Gene Circuits for Cancer Immunotherapy","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Bgf04dUNhbmDqfwW9yz4f8RrVu5Rbq4o3o8uY4ywGEPW1MSWP2uufl","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JrS5e8KDA","name":"Epeius Pharma","hidden":false,"raised":"$3.5M","founded":"2019","fullurl":"/company_page/epeius-pharma","logokey":"$aCsMgRtMJ5NaRfTHM6vARJdYzNC2qWOo9SewbRIYb4FI8IlOz8Diih","urlname":"epeius-pharma","employees":"1-10","description":"Delivery of Therapeutic Proteins into the Central Nervous System","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":3500000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$aCsMgRtMJ5NaRfTHM6vARJdYzNC2qWOo9SewbRIYb4FI8IlOz8Diih","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoL3etN4IDA","name":"Glixogen Therapeutics","hidden":false,"raised":"undisclosed","founded":"2018","fullurl":"/company_page/glixogen-therapeutics","logokey":"$DoECn0U5M7jgPcTDcuNmBYXMOPssdYEhBZLtJtnHA4xTOuI9pvZaaE","urlname":"glixogen-therapeutics","employees":"1-10","description":"Treatment for Enhancing Remyelination in Neurodegenerative Disorders","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$DoECn0U5M7jgPcTDcuNmBYXMOPssdYEhBZLtJtnHA4xTOuI9pvZaaE","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOH20pAJDA","name":"HepaRx","hidden":false,"raised":"undisclosed","founded":"2014","fullurl":"/company_page/heparx","logokey":"$UpoVncgg4kLjUBKUIfhppvaHu2ndr1NJ87d2m0UNXfaji09ezXt5CD","urlname":"heparx","employees":"1-10","description":"Small Molecule Cancer Drugs","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$UpoVncgg4kLjUBKUIfhppvaHu2ndr1NJ87d2m0UNXfaji09ezXt5CD","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPH9tMALDA","name":"ImmPACT Bio","hidden":false,"raised":"$137M","founded":"2017","fullurl":"/company_page/immpact-bio","logokey":"$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","urlname":"immpact-bio","employees":"11-50","description":"CAR-T Cell Therapies for Treating Cancer","fundingstage":"Acquired","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":137000000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4IGF5ckIDA","name":"JAMM Therapeutics","hidden":false,"raised":"undisclosed","founded":"2019","fullurl":"/company_page/jamm-therapeutics","logokey":"$ijXlOprzOfiSZPyysT94sknvgvYEsNheSxah4ygktIiLipMli36D7m","urlname":"jamm-therapeutics","employees":"1-10","description":"Systemic Lupus Erythematosus Treatment","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ijXlOprzOfiSZPyysT94sknvgvYEsNheSxah4ygktIiLipMli36D7m","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoImCyu8LDA","name":"MabTrix","hidden":false,"raised":"undisclosed","founded":"2015","fullurl":"/company_page/mabtrix","logokey":"$zqr7oQ1lUKUaafqaNX64l2MhNpRIEaIfqkyOZK2YIPP028Ha9dbLyZ","urlname":"mabtrix","employees":"1-10","description":"Therapeutic Monoclonal Antibody for Bowel Disease","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$zqr7oQ1lUKUaafqaNX64l2MhNpRIEaIfqkyOZK2YIPP028Ha9dbLyZ","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwIe57McJDA","name":"Mitoconix Bio","hidden":false,"raised":"$20M","founded":"2016","fullurl":"/company_page/mitoconix","logokey":"$APgDyiBVWJ0frs3eDIrKJrr6BPavgsuOaxae7GXLbAvREDwcatLVTU","urlname":"mitoconix","employees":"1-10","description":"Therapeutics for Neurodegenerative Diseases","fundingstage":"A","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":20000000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$APgDyiBVWJ0frs3eDIrKJrr6BPavgsuOaxae7GXLbAvREDwcatLVTU","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NSu4YsLDA","name":"Moya Bio","hidden":false,"raised":"$3M","founded":"2017","fullurl":"/company_page/moya-bio","logokey":"$I0NMGQyfFWZkCeZ9vs4ca6oSgOOxNEefLEjHtWE0u1hiEP2xSPT9iZ","urlname":"moya-bio","employees":"1-10","description":"Tumor Immune Conditioning Agents","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":3000000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$I0NMGQyfFWZkCeZ9vs4ca6oSgOOxNEefLEjHtWE0u1hiEP2xSPT9iZ","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Oua4M0LDA","name":"Nevrox","hidden":false,"raised":"undisclosed","founded":"2019","fullurl":"/company_page/nevrox","logokey":"$cCF7yvuVUgi0gOf7NTvFx4673qJakXg7RRrjB3dHOwoAHqfHqzsCfy","urlname":"nevrox","employees":"1-10","description":"Therapeutic Small Molecule Inhibitor for Treating Neurodegenerative Disorders","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$cCF7yvuVUgi0gOf7NTvFx4673qJakXg7RRrjB3dHOwoAHqfHqzsCfy","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMWF04oKDA","name":"Pi Therapeutics","hidden":false,"raised":"$19.7M","founded":"2015","fullurl":"/company_page/pi-therapeutics","logokey":"$OyG5CyFfWgh7q4iqQSs0SFeZpxjTILEQwYMzLDDlhqDQZnXrM9s79x","urlname":"pi-therapeutics","employees":"1-10","description":"Inhibitors for Cancer Treatment","fundingstage":"B","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":19700000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OyG5CyFfWgh7q4iqQSs0SFeZpxjTILEQwYMzLDDlhqDQZnXrM9s79x","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMOo3csIDA","name":"Pink Biopharma","hidden":false,"raised":"$3M","founded":"2018","fullurl":"/company_page/pink-biopharma","logokey":"$mcXfrroovU8RksIMczZePIWIkITZ9k8GPR03s93SbKks8K7ypBTFXM","urlname":"pink-biopharma","employees":"1-10","description":"Monoclonal Antibody Therapy for Blood and Bone Cancer","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":3000000,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$mcXfrroovU8RksIMczZePIWIkITZ9k8GPR03s93SbKks8K7ypBTFXM","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwJKrsJMLDA","name":"Protekt Therapeutics ","hidden":false,"raised":"$13.85M","founded":"2014","fullurl":"/company_page/protekt-therapeutics","logokey":"$PUC7R9TDFPF3OWeavgoDg0BM7Cm0A86pfcVq05rYY1jqIa8S27qERK.png","urlname":"protekt-therapeutics","employees":"1-10","description":"PKR Inhibition for Treating Neurodegenerative Diseases","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":2250000,"companyvisibility":"Public","portfoliovisibility":null,"blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$PUC7R9TDFPF3OWeavgoDg0BM7Cm0A86pfcVq05rYY1jqIa8S27qERK.png","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPW1rIQKDA","name":"Ramino-Bio","hidden":false,"raised":"undisclosed","founded":"2018","fullurl":"/company_page/ramino-bio","logokey":"$WvRJwfWgivA3mwtUF6FGxbkRFzQwkB9Iittd7EeUusK1t52K3AMj2M","urlname":"ramino-bio","employees":"1-10","description":"Oral drug for treating cardio-metabolic disease and rare MSUD","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$WvRJwfWgivA3mwtUF6FGxbkRFzQwkB9Iittd7EeUusK1t52K3AMj2M","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4LPGuIwJDA","name":"Selene Therapeutics","hidden":false,"raised":"undisclosed","founded":"2020","fullurl":"/company_page/selene-therapeutics","logokey":"$MKZb3x7pjbftW98tMfB6tH6lUMEse6YTL7tggzg5FdpA63GTYZFYpf","urlname":"selene-therapeutics","employees":"1-10","description":"Epilepsy Therapy","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$MKZb3x7pjbftW98tMfB6tH6lUMEse6YTL7tggzg5FdpA63GTYZFYpf","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkMjG_IIKDA","name":"Skip Therapeutics","hidden":false,"raised":"undisclosed","founded":"2021","fullurl":"/company_page/skip-therapeutics","logokey":"$4xnVGxyOkOrXscYMAgkjJPgr1aFlQLbf1NwYFzNsAWTgHudWhwbZZB","urlname":"skip-therapeutics","employees":"1-10","description":"RNA-based Therapies for Genetic Disorders","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$4xnVGxyOkOrXscYMAgkjJPgr1aFlQLbf1NwYFzNsAWTgHudWhwbZZB","style":"","hiddenCompanyTooltip":""},{"id":"fu28G8iupXNtPfYur9rnvHRSjnN4pQkfOnHNPu9GUWsPiFWKueCw7m","name":"Symbol Therapeutics","hidden":false,"raised":"$3M","founded":"2021","fullurl":"/company_page/symbol-therapeutics","logokey":"$3vFKuc0yaI3n8KxFo9RAYNvZPUUhLAXvE3RcQNVdMQ5pFFzhxw0asA","urlname":"symbol-therapeutics","employees":"1-10","description":"Modified Protein for Treatment of Autoimmune Diseases","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":3000000,"companyvisibility":"Public","portfoliovisibility":null,"blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3vFKuc0yaI3n8KxFo9RAYNvZPUUhLAXvE3RcQNVdMQ5pFFzhxw0asA","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JyV-agJDA","name":"TNIK Therapeutics","hidden":false,"raised":"undisclosed","founded":"2018","fullurl":"/company_page/tnik-therapeutics","logokey":"$dNSORFPzKetg0B7WZNd8ZkgqxxzSBcCexFJQWeI60T7f7j85gO1So5","urlname":"tnik-therapeutics","employees":"1-10","description":"Small Molecule Inhibitors of TNIK","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$dNSORFPzKetg0B7WZNd8ZkgqxxzSBcCexFJQWeI60T7f7j85gO1So5","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMmt05AKDA","name":"XL Therapeutics","hidden":false,"raised":"undisclosed","founded":"2016","fullurl":"/company_page/xl-therapeutics","logokey":"$2qRceKXqSxbTh4WEw8e8BZuO8TdSVBLgTur1sK9sXQxJPy8WRZEuHT","urlname":"xl-therapeutics","employees":"1-10","description":"Treatment of Conditions Caused by Deficiencies in WAS Protein Expression","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$2qRceKXqSxbTh4WEw8e8BZuO8TdSVBLgTur1sK9sXQxJPy8WRZEuHT","style":"","hiddenCompanyTooltip":""},{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOG7-ssJDA","name":"XoNovo","hidden":false,"raised":"undisclosed","founded":"2013","fullurl":"/company_page/xonovo","logokey":"$kzBqlSdyKOuIs7ULWljurjP0efxvK7IuubaQEMbTNrsc0zSI95vpxD","urlname":"xonovo","employees":"11-50","description":"Small-molecule Drugs for Neurodegenerative Diseases","fundingstage":"Seed","businessmodel":"B2B","minimalprofile":null,"eventvisibility":"Public","publicly_raised":0,"companyvisibility":"Public","portfoliovisibility":"Public","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$kzBqlSdyKOuIs7ULWljurjP0efxvK7IuubaQEMbTNrsc0zSI95vpxD","style":"","hiddenCompanyTooltip":""}],"investments":[{"date":"Sep 2022","name":"Symbol Therapeutics","amount":3000000,"hidden":false,"islead":0,"country":null,"eventid":"YeTDK2zREIXSGbJXfHBeZ3ayn92iMk6RjLEpV7SNln0ZacbJ3L2t4e","fullurl":"/company_page/symbol-therapeutics","logokey":"$3vFKuc0yaI3n8KxFo9RAYNvZPUUhLAXvE3RcQNVdMQ5pFFzhxw0asA","tagline":"Modified Protein for Treatment of Autoimmune Diseases","urlname":"/company_page/symbol-therapeutics","companyid":"fu28G8iupXNtPfYur9rnvHRSjnN4pQkfOnHNPu9GUWsPiFWKueCw7m","isfollowon":0,"companytype":"Startup","eventamount":"$3M","fundingtype":"Seed","investmentid":"ihAHvD5B0sS3fiVMSCinnmbm0ePTFjWy9di4ovmmnqEjuVj770ZNoX","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":null,"leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3vFKuc0yaI3n8KxFo9RAYNvZPUUhLAXvE3RcQNVdMQ5pFFzhxw0asA","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Dec 2021","name":"CatchMe Theraputics","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"HjemKrUFNnTKwAl3NLaNfuuTHui8xGCd5BV6Bd4H21UB8QParrhxHv","fullurl":"/company_page/catchme-theraputics","logokey":"$jtt828Tyc5cy5glT1RAP5Ty1mrDWEU8ue7jZIv3y8YQulFynCojskt","tagline":"Precision Medicine for Epitranscriptome Machinery","urlname":"/company_page/catchme-theraputics","companyid":"emKJyaS3AEzL2oByNresmGZiMiqXwcRSN8QcXjNo4GtFtWO0Kjrg5r","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Pre-Seed","investmentid":"aerutId48Om6vSC1fLVHP1CgNYJTSZ0ti01nPOphJfOLc36zz7Dxf2","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$jtt828Tyc5cy5glT1RAP5Ty1mrDWEU8ue7jZIv3y8YQulFynCojskt","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"May 2021","name":"Skip Therapeutics","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDIhqDfCww","fullurl":"/company_page/skip-therapeutics","logokey":"$4xnVGxyOkOrXscYMAgkjJPgr1aFlQLbf1NwYFzNsAWTgHudWhwbZZB","tagline":"RNA-based Therapies for Genetic Disorders","urlname":"/company_page/skip-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkMjG_IIKDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Seed","investmentid":"bf59fe75-ab88-41cd-8b8a-690f0ed1009b","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$4xnVGxyOkOrXscYMAgkjJPgr1aFlQLbf1NwYFzNsAWTgHudWhwbZZB","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Nov 2020","name":"A2i Therapeutics","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODjv5baCww","fullurl":"/company_page/a2i-therapeutics","logokey":"$0K5XoGaROr8DhBGwnNwsFMah69flclMsHMwteKb7FvfSTjSDdS1zL6","tagline":"Novel Small-molecule Immuno-oncology Agents","urlname":"/company_page/a2i-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NPYqOgKDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Seed","investmentid":"edff58ab-b8e0-4bc7-b4c5-9262bfdabd6e","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$0K5XoGaROr8DhBGwnNwsFMah69flclMsHMwteKb7FvfSTjSDdS1zL6","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Oct 2020","name":"Selene Therapeutics","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgJDIpcHgCAw","fullurl":"/company_page/selene-therapeutics","logokey":"$MKZb3x7pjbftW98tMfB6tH6lUMEse6YTL7tggzg5FdpA63GTYZFYpf","tagline":"Epilepsy Therapy","urlname":"/company_page/selene-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4LPGuIwJDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Seed","investmentid":"f4e055ec-c6c1-4d4e-92c0-8872fab141f4","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$MKZb3x7pjbftW98tMfB6tH6lUMEse6YTL7tggzg5FdpA63GTYZFYpf","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Sep 2020","name":"Circuit-Bio","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODv4ZaWCQw","fullurl":"/company_page/circuit-bio","logokey":"$Bgf04dUNhbmDqfwW9yz4f8RrVu5Rbq4o3o8uY4ywGEPW1MSWP2uufl","tagline":"Platform of Logical Gene Circuits for Cancer Immunotherapy","urlname":"/company_page/circuit-bio","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JnHu9sJDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Seed","investmentid":"0305b834-4a29-4fe2-a698-0165c6561d45","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$Bgf04dUNhbmDqfwW9yz4f8RrVu5Rbq4o3o8uY4ywGEPW1MSWP2uufl","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"May 2020","name":"JAMM Therapeutics","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD-w9aMCQw","fullurl":"/company_page/jamm-therapeutics","logokey":"$ijXlOprzOfiSZPyysT94sknvgvYEsNheSxah4ygktIiLipMli36D7m","tagline":"Systemic Lupus Erythematosus Treatment","urlname":"/company_page/jamm-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4IGF5ckIDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Seed","investmentid":"83de53c1-7e21-49ed-976b-ecd5b981cb46","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$ijXlOprzOfiSZPyysT94sknvgvYEsNheSxah4ygktIiLipMli36D7m","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Nov 2019","name":"Protekt Therapeutics ","amount":3600000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODK05y6CAw","fullurl":"/company_page/protekt-therapeutics","logokey":"$PUC7R9TDFPF3OWeavgoDg0BM7Cm0A86pfcVq05rYY1jqIa8S27qERK.png","tagline":"PKR Inhibition for Treating Neurodegenerative Diseases","urlname":"/company_page/protekt-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwJKrsJMLDA","isfollowon":0,"companytype":"Startup","eventamount":"$3.6M","fundingtype":"Undisclosed Round","investmentid":"76bc36b9-b127-4560-b470-7e34e0b5a47e","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Private","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":null,"investmentamountvisibility":null,"leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"private-visibility","amountvisibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>Private</text>\n</div>'","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$PUC7R9TDFPF3OWeavgoDg0BM7Cm0A86pfcVq05rYY1jqIa8S27qERK.png","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Nov 2019","name":"Nevrox","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODriKDKCww","fullurl":"/company_page/nevrox","logokey":"$cCF7yvuVUgi0gOf7NTvFx4673qJakXg7RRrjB3dHOwoAHqfHqzsCfy","tagline":"Therapeutic Small Molecule Inhibitor for Treating Neurodegenerative Disorders","urlname":"/company_page/nevrox","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Oua4M0LDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Seed","investmentid":"c3adce31-d4fd-4a5b-a165-a75ea37a1e55","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$cCF7yvuVUgi0gOf7NTvFx4673qJakXg7RRrjB3dHOwoAHqfHqzsCfy","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Feb 2019","name":"Epeius Pharma","amount":3500000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODKis_2Cgw","fullurl":"/company_page/epeius-pharma","logokey":"$aCsMgRtMJ5NaRfTHM6vARJdYzNC2qWOo9SewbRIYb4FI8IlOz8Diih","tagline":"Delivery of Therapeutic Proteins into the Central Nervous System","urlname":"/company_page/epeius-pharma","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JrS5e8KDA","isfollowon":0,"companytype":"Startup","eventamount":"$3.5M","fundingtype":"Seed","investmentid":"89d464d3-1b67-4c93-a95a-6c940883f3b6","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$aCsMgRtMJ5NaRfTHM6vARJdYzNC2qWOo9SewbRIYb4FI8IlOz8Diih","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2019","name":"Moya Bio","amount":3000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD0sP-NCww","fullurl":"/company_page/moya-bio","logokey":"$I0NMGQyfFWZkCeZ9vs4ca6oSgOOxNEefLEjHtWE0u1hiEP2xSPT9iZ","tagline":"Tumor Immune Conditioning Agents","urlname":"/company_page/moya-bio","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4NSu4YsLDA","isfollowon":0,"companytype":"Startup","eventamount":"$3M","fundingtype":"Seed","investmentid":"3520f828-73d9-4f03-8212-45dcd5799388","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$I0NMGQyfFWZkCeZ9vs4ca6oSgOOxNEefLEjHtWE0u1hiEP2xSPT9iZ","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2019","name":"Glixogen Therapeutics","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCf_9uVCAw","fullurl":"/company_page/glixogen-therapeutics","logokey":"$DoECn0U5M7jgPcTDcuNmBYXMOPssdYEhBZLtJtnHA4xTOuI9pvZaaE","tagline":"Treatment for Enhancing Remyelination in Neurodegenerative Disorders","urlname":"/company_page/glixogen-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoL3etN4IDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Seed","investmentid":"99c9a0d0-cee5-44e5-a428-dcf23bba0701","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$DoECn0U5M7jgPcTDcuNmBYXMOPssdYEhBZLtJtnHA4xTOuI9pvZaaE","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2019","name":"TNIK Therapeutics","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCcle6xCww","fullurl":"/company_page/tnik-therapeutics","logokey":"$dNSORFPzKetg0B7WZNd8ZkgqxxzSBcCexFJQWeI60T7f7j85gO1So5","tagline":"Small Molecule Inhibitors of TNIK","urlname":"/company_page/tnik-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4JyV-agJDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Undisclosed Round","investmentid":"a36fc07c-c33b-4099-824e-4b2b6b5212e5","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$dNSORFPzKetg0B7WZNd8ZkgqxxzSBcCexFJQWeI60T7f7j85gO1So5","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Oct 2018","name":"Pink Biopharma","amount":3000000,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODk3aneCgw","fullurl":"/company_page/pink-biopharma","logokey":"$mcXfrroovU8RksIMczZePIWIkITZ9k8GPR03s93SbKks8K7ypBTFXM","tagline":"Monoclonal Antibody Therapy for Blood and Bone Cancer","urlname":"/company_page/pink-biopharma","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMOo3csIDA","isfollowon":0,"companytype":"Startup","eventamount":"$3M","fundingtype":"Seed","investmentid":"2d9858c8-9cc2-4ba8-8417-a8ff3e971aa6","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$mcXfrroovU8RksIMczZePIWIkITZ9k8GPR03s93SbKks8K7ypBTFXM","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Sep 2018","name":"Ramino-Bio","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCEnti4CQw","fullurl":"/company_page/ramino-bio","logokey":"$WvRJwfWgivA3mwtUF6FGxbkRFzQwkB9Iittd7EeUusK1t52K3AMj2M","tagline":"Oral drug for treating cardio-metabolic disease and rare MSUD","urlname":"/company_page/ramino-bio","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPW1rIQKDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Seed","investmentid":"691960e3-4b4a-4b86-b878-6adbb4b6ca71","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$WvRJwfWgivA3mwtUF6FGxbkRFzQwkB9Iittd7EeUusK1t52K3AMj2M","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Sep 2018","name":"Bsense Bio Therapeutics","amount":2700000,"hidden":false,"islead":null,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOD42_qgCww","fullurl":"/company_page/bsense-bio-therapeutics","logokey":"$dOA6SUmJ7D9W3bQfbCYcVFJHbmrHRWX98ITS6MJvD3MF0vJXXqlzdW","tagline":"Neuropathic Pain Treatment","urlname":"/company_page/bsense-bio-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoJ2LioYKDA","isfollowon":0,"companytype":"Startup","eventamount":"$2.7M","fundingtype":"Seed","investmentid":"deb50a1a-eadf-49f8-bf67-219cd8b754a2","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$dOA6SUmJ7D9W3bQfbCYcVFJHbmrHRWX98ITS6MJvD3MF0vJXXqlzdW","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"May 2017","name":"MabTrix","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"xC1uN2JhnzAIkPAA2OCXoWNOphD5teX3Sh8GMmFVAD8994KPOVpvW3","fullurl":"/company_page/mabtrix","logokey":"$zqr7oQ1lUKUaafqaNX64l2MhNpRIEaIfqkyOZK2YIPP028Ha9dbLyZ","tagline":"Therapeutic Monoclonal Antibody for Bowel Disease","urlname":"/company_page/mabtrix","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoImCyu8LDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Undisclosed Round","investmentid":"5BkJjSOZ02l87aExbR6GhOwfVB8BSSO0soNgkaQYcsEuLqZQJRz6kO","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":null,"leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$zqr7oQ1lUKUaafqaNX64l2MhNpRIEaIfqkyOZK2YIPP028Ha9dbLyZ","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"May 2017","name":"XL Therapeutics","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"P3iI0PLBTMC7WUhlkTX3qbZ1RkCsLU9kwClOxm4EvRYlqSeIg8Sl0b","fullurl":"/company_page/xl-therapeutics","logokey":"$2qRceKXqSxbTh4WEw8e8BZuO8TdSVBLgTur1sK9sXQxJPy8WRZEuHT","tagline":"Treatment of Conditions Caused by Deficiencies in WAS Protein Expression","urlname":"/company_page/xl-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoMmt05AKDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Undisclosed Round","investmentid":"EzzQaTJsM1lvoHBgZehoKA721EtfLA8xEtHn2dFlseYMMdg5XL9qYh","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":null,"leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$2qRceKXqSxbTh4WEw8e8BZuO8TdSVBLgTur1sK9sXQxJPy8WRZEuHT","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"May 2017","name":"HepaRx","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"3ayrUUlpRdD9YQ9kk7tG8geb1f8gtGh79pZnBRP6uSZgkQYP2tYeFV","fullurl":"/company_page/heparx","logokey":"$UpoVncgg4kLjUBKUIfhppvaHu2ndr1NJ87d2m0UNXfaji09ezXt5CD","tagline":"Small Molecule Cancer Drugs","urlname":"/company_page/heparx","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOH20pAJDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Undisclosed Round","investmentid":"GWwyRpnN6xBcSrfsTema4LfZJT1yAMpLz2CbDvnIRitos4eK5o8v0Z","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":null,"leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$UpoVncgg4kLjUBKUIfhppvaHu2ndr1NJ87d2m0UNXfaji09ezXt5CD","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2017","name":"Pi Therapeutics","amount":0,"hidden":false,"islead":null,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCk8IHSCgw","fullurl":"/company_page/pi-therapeutics","logokey":"$OyG5CyFfWgh7q4iqQSs0SFeZpxjTILEQwYMzLDDlhqDQZnXrM9s79x","tagline":"Inhibitors for Cancer Treatment","urlname":"/company_page/pi-therapeutics","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMWF04oKDA","isfollowon":0,"companytype":"Startup","eventamount":"$0","fundingtype":"Seed","investmentid":"aa65192b-50b7-478f-ad9a-438d15e38be9","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$OyG5CyFfWgh7q4iqQSs0SFeZpxjTILEQwYMzLDDlhqDQZnXrM9s79x","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Aug 2016","name":"Mitoconix Bio","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"9u06L416gx8nBkVTYAgRzYM9JSTFmdIiVPISRG7szxlJOihwAStKzP","fullurl":"/company_page/mitoconix","logokey":"$APgDyiBVWJ0frs3eDIrKJrr6BPavgsuOaxae7GXLbAvREDwcatLVTU","tagline":"Therapeutics for Neurodegenerative Diseases","urlname":"/company_page/mitoconix","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwIe57McJDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Undisclosed Round","investmentid":"fwUOXPgeJ7YKeAp5ePsMCMu7chtgEKihKw83lmEW9TQevzKJ8Vbbji","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":null,"leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$APgDyiBVWJ0frs3eDIrKJrr6BPavgsuOaxae7GXLbAvREDwcatLVTU","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jul 2016","name":"ImmPACT Bio","amount":null,"hidden":false,"islead":0,"country":null,"eventid":"CpnZ1Gj5bXu2tT6AFzF8dec29Po5p9YIPXxmsBXbUqO4QdLbeRfDie","fullurl":"/company_page/immpact-bio","logokey":"$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","tagline":"CAR-T Cell Therapies for Treating Cancer","urlname":"/company_page/immpact-bio","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoPH9tMALDA","isfollowon":0,"companytype":"Startup","eventamount":"Undisclosed","fundingtype":"Undisclosed Round","investmentid":"bbTax7BUa047eE2MSC0t0yoimkxlG6c9o7BEGJHLlHs1DTfcrydpn6","investoramount":null,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":null,"leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$3p73CkjSNEmQu8LgGFlmc6xpIulpBCVUZki53yQExPwplQjpKKvKXP","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":null,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Dec 2015","name":"BiomX","amount":0,"hidden":false,"islead":null,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE7uruCgw","fullurl":"/company_page/mbcure","logokey":"$HdbYudOBbsqnaiwKQswzUrkLLKVKTiKxHZ8NwUkSmdDf9iGxWcCNTl","tagline":"Microbiome Therapies for Chronic Diseases","urlname":"/company_page/mbcure","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgLfx744KDA","isfollowon":null,"companytype":"Startup","eventamount":"$0","fundingtype":"Seed","investmentid":"be177ae7-d959-40d2-82bd-d626b09abc38","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$HdbYudOBbsqnaiwKQswzUrkLLKVKTiKxHZ8NwUkSmdDf9iGxWcCNTl","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""},{"date":"Jan 2015","name":"XoNovo","amount":0,"hidden":false,"islead":null,"country":null,"eventid":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmt33CQw","fullurl":"/company_page/xonovo","logokey":"$kzBqlSdyKOuIs7ULWljurjP0efxvK7IuubaQEMbTNrsc0zSI95vpxD","tagline":"Small-molecule Drugs for Neurodegenerative Diseases","urlname":"/company_page/xonovo","companyid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwOG7-ssJDA","isfollowon":null,"companytype":"Startup","eventamount":"$0","fundingtype":"Undisclosed Round","investmentid":"7abb2e98-442a-4177-9c25-5597294d1a6a","investoramount":0,"minimalprofile":null,"eventvisibility":"Public","is_silent_round":null,"amountvisibility":"Public","leadpartnercompany_id":null,"funding_type_visibility":"Public","investmenteventvisibility":"Public","investmentamountvisibility":"Public","leadpartnercompany_logokey":"","leadpartneruser_picturekey":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","funding_type_visibilityClassName":"","funding_type_visibilityTooltip":"","blurFinancialData":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$kzBqlSdyKOuIs7ULWljurjP0efxvK7IuubaQEMbTNrsc0zSI95vpxD","leadpartnercompany_logourl":"/assets/empty-state.svg","leadpartneruser_pictureurl":"/assets/empty-state.svg","investoramountnumber":0,"foreignInvestmentLabel":{"display":"none"},"style":"","hiddenCompanyTooltip":""}],"team":[{"name":"Lianna Patt","email":"iana@futurx.co.il","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkIKC9IUKDA","bounced":true,"claimed":0,"founder":0,"urlname":"lianna-patt","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQvNvQrwkM","position":"CEO","last_name":"Patt","claimtoken":"LZdzzeijIyLkSyDmMPuphBsAK7CYovSUHQKS53lF3vGN4YQFlWqcBK","first_name":"Lianna","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/liana-patt/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-10-25 09:16:31.000000","initials":"LP","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Modi Teicher","email":"modi@futurx.co.il","phone":"","gender":"Male","userid":"u9w3ummqQe68IFJov1IHSrtuMR8jEJuNw8H4SGPC8wCLDHpvueqDgn","bounced":false,"claimed":null,"founder":0,"urlname":"modi-teicher-3","visible":1,"memberid":"hczd4od4NSdtXaSuLrJJR4QCUh42hrdGCDSYZYafgqJUMvW5EIqIey","position":"CBO","last_name":"Teicher","claimtoken":"KvzxXYRmse22U7v6iKWe1UsrUXE3mbhe42w6tKjInynw3DkUzzRUGd","first_name":"Modi","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/modi-teicher-29444b8/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-10-25 09:19:07.000000","initials":"MT","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Aric Orbach","email":"Aric@futurx.co.il","phone":"","gender":"Male","userid":"B1q4UOPdtTGbxwuTScvdtr7bit2RiRJRMDJbH4sDunmmdPlgUc33Ee","bounced":false,"claimed":null,"founder":0,"urlname":"aric-orbach","visible":1,"memberid":"42cCIr83sZB9yOezc6mfBhAzpQmLbXky5OFRyhZyAnBojsqbYVStMA","position":"CTO","last_name":"Orbach","claimtoken":"7kHtLkW3M7TNzxJRCMJnBTwuM2uiv0CcnAwAmmOw8u5rulAVueBJPY","first_name":"Aric","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/aric-orbach-12729722/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2022-10-25 09:20:13.000000","initials":"AO","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Inbal  Michailovici","email":"inbal@futurx.co.il","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkMLmhKIIDA","bounced":false,"claimed":0,"founder":0,"urlname":"inbal-michailovici-1","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQvMzH_ggM","position":"Director of Business Development","last_name":"Michailovici","claimtoken":"FISjzBBoWNINlBYzfXtIroeQ7m3mNb8f1h4sd5Hd1jbXPzXlEQV37H","first_name":"Inbal ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/inbal-michailovici-32925432/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-10-25 09:16:19.000000","initials":"IM","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Shahar Nir","email":"shahar@futurx.co.il","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAkPyipLsKDA","bounced":false,"claimed":0,"founder":0,"urlname":"shahar-nir","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICQ_PHrxAoM","position":"HR Manager","last_name":"Nir","claimtoken":"Gx07B4LKHYM3SWIkrd0Ap4n8qvttRepR34anQoDyXbVDVA2ccBaWHs","first_name":"Shahar","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/shahar-nir-175871112/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2022-10-25 09:15:49.000000","initials":"SN","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"tags":["drug-discovery","biopharmaceutical","therapeutics","biotechnology","pharmaceuticals"],"targetmarkets":[],"phone":"+97289553100","address":{"israeli":[{"id":"12721NGBaTX2K2nXRZ7nfEIm4eTPFVjXJhVhCpPk3GBFATEMyvB3WD","city":"Ness Ziona","type":null,"address":"Park Hamada Ilan Ramon St 2, Ness Ziona, Israel","placeid":null,"notactive":null,"openeddate":null,"registrarid":null,"firstrdcenter":null,"registrarname":null}],"officesabroad":[]},"headquarter_address":"","news":[{"id":"bb719ee5-82f8-4f4c-98e0-ae1830a3994f","date":"Dec 18, 2020","link":"https://www.businesswire.com/news/home/20201218005044/en/","source":"www.businesswire.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"6DXQGOpWimUCbkbJhGz3yz4y48xywsN0tC1tMEBS90LiAEFFBn71jm","news_summary":"Atomwise and FutuRx Launch A2i Therapeutics - A New Immuno-Oncology Company Funded By Leading Biopharma VCs and the Israeli Innovation Authority","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"a935c3c6-b1b3-46ed-bb17-3f8a89b4d12f","date":"Jul 28, 2020","link":"https://www.marketwatch.com/press-release/biotech-incubator-futurx-announces-new-investor-leaps-by-bayer-2020-07-28","source":"www.marketwatch.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"VJsMb1Uzlyy4zqIficwJr3SKtJp6ghGVjMPBCyEZamAfI6O98IQRv7","news_summary":"https://www.marketwatch.com/press-release/biotech-incubator-futurx-announces-new-investor-leaps-by-bayer-2020-07-28","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"bd745241-4515-4895-a598-a501be961716","date":"Apr 8, 2019","link":"https://en.globes.co.il/en/article-rm-global-raises-64m-for-futurx-investments-1001281543","source":"en.globes.co.il","visible":1,"analysis":{"tags":["investment","partners"],"company":"RM Global","layoffs":null,"summary":"RM Global has closed a second financing round of $34 million for its RMGP Biopharma investment fund. The fund aims to invest in companies at the FutuRx biotech incubator in Ness Ziona, Israel. The first financing round of $30 million was held in 2017. RMGP Biopharma brings capital and connections to the table without being a franchise holder, allowing them to invest selectively in companies in the incubator. The investors in the fund are primarily life sciences investment institutions, funds, and non-mega pharma companies from the US, Israel, South America, and Asia. RMGP Biopharma has already made investments in companies such as BiomX, Mitoconix Bio, Pi Therapeutics, Bsense Bio Therapeutics, PiNK Biopharma, and ImmPACT-Bio. The fund aims to support these companies until they hold IPOs.","partners":null,"customers":null,"investors":"aMoon fund","confidence":9,"key_topics":["investment","biotech incubator","fundraising","investors","startups"],"date_of_event":"April 8, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$34 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"L6S5JNeDyMG9RMAS5qMF3Yjy0wUL8uULyam7uTRjVcw3oP4DjlMDEd","news_summary":"RM Global raises $64m for FutuRx investments","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"810a8bea-d18a-4f91-b877-be872f0f758c","date":"May 19, 2017","link":"http://www.globes.co.il/en/article-rm-global-to-invest-$30m-in-futurx-biotech-startups-1001189272","source":"www.globes.co.il","visible":1,"analysis":{"tags":"venture capital","company":"RM Global","layoffs":null,"summary":"US-based international investment bank RM Global is establishing a new venture capital fund that has already closed its first financing round of $30 million and will soon embark on a second financing round. The fund will invest exclusively in companies operating in Israels FutuRx incubator (accelerator) in Ness Ziona near Rehovot. The fund has raised money from financial and strategic investors, and hopes to raise additional tens of millions of dollars.","partners":["OrbiMed Israel Partners","Johnson & Johnson Innovation","Takeda Ventures"],"customers":null,"investors":null,"confidence":8,"key_topics":["venture capital","biotech incubator","investment","Israel","early-stage companies"],"date_of_event":"May 18, 2017","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$30 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"9iGZESdRz6qCbQJ9uF2s5rnZnzL2dy00XJGZ7cpgPq3U07yKau1j52","news_summary":"RM Global to invest $30m in FutuRx biotech startups","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"701c61be-cdb5-403c-897b-349dba2a1a46","date":"Jan 19, 2015","link":"http://www.timesofisrael.com/jj-takeda-team-up-to-open-israeli-biotech-incubator/","source":"www.timesofisrael.com","visible":1,"analysis":{"tags":"collaboration, biotechnology incubator","company":"Johnson and Johnson","layoffs":null,"summary":"Johnson and Johnson, along with Takeda Pharmaceuticals and OrbiMed, has opened a biotechnology incubator in the Weizmann Science Park in Israel. The incubator, called FutuRx, has enrolled its first two members, Hepy Biosciences and XoNovo. The companies will be funded up to $2 million, with the Chief Scientists Office providing 85% of the funding. Johnson and Johnson and its partners have pledged over $28 million to fund companies in the incubator. The incubator aims to support early-stage biopharm companies that may not have been able to obtain financing through regular channels. The collaboration between government, industry, and venture capital provides a unique platform for funding and strategic advice.","partners":"Takeda Pharmaceuticals, OrbiMed","customers":null,"investors":"Japanese pharmaceutical giant Takeda Pharmaceuticals, venture capital firm OrbiMed","confidence":8,"key_topics":["pharmaceutical firms","biotechnology incubator","life sciences start-ups","funding","strategic advice"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"PQTk0BaM6TuazHPuqJJkja7Fw0eH6LUxkbRGIUBbPvQgmuZYNAUAvm","news_summary":"J&J, Takeda team up to open Israeli biotech incubator","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"dc617268-49c7-4c2b-912d-505d2d196fb9","date":"Jan 14, 2015","link":"http://www.globes.co.il/en/article-new-biotech-incubator-selects-first-two-projects-1001000994","source":"www.globes.co.il","visible":1,"analysis":{"tags":"biotechnology, pharmaceuticals","company":"XoNovo","layoffs":null,"summary":"XoNovo, a biotech startup, has entered an incubator program and received investments from OrbiMed Advisors LLC, Johnson and Johnson, and Takeda Pharmaceutical. The company is developing a drug to treat Alzheimers Disease and other brain degenerative diseases. The drug has shown positive results in animal trials, reducing cognitive degeneration and the accumulation of disease-related materials in the brain. XoNovo will also focus on treating Batten, an orphan disease. The incubator program provides financing to high-risk companies, with the state covering 85% of the budget. The goal is to consolidate the bio-pharma industry in Israel. Another company in the incubator program is Hepy Biosciences, which is developing a cancer drug. The program aims to support the development of medical technology for the benefit of patients.","partners":["OrbiMed Advisors LLC","Johnson and Johnson","Takeda Pharmaceutical"],"customers":null,"investors":["OrbiMed Advisors LLC","Johnson and Johnson","Takeda Pharmaceutical"],"confidence":8,"key_topics":["Alzheimers Disease","brain degeneration","cancer","biotechnology","pharmaceuticals"],"date_of_event":"January 14, 2015","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"NIS 8 million","structured_issues":["Investment"],"acquisition_amount":null,"structuredIssuesShow":"#Investment","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"6HgdQNxM5f0moHChlZTMXRMKrJDKt6LjHJjxSvQRGNnOs4wJwKSfxv","news_summary":"FutuRx biotech incubator selects first two projects","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"c2d469fc-9822-42bb-b334-228e3d06016f","date":"Oct 2, 2014","link":"http://www.israel21c.org/israel-takes-a-risk-on-tomorrows-epic-drugs/","source":"www.israel21c.org","visible":1,"analysis":{"tags":"biotechnology accelerator","company":"FutuRx","layoffs":null,"summary":"FutuRx, an Israeli biotechnology accelerator, has received backing from OrbiMed Israel Partners, Johnson & Johnson, and Takeda Ventures. The accelerator aims to incubate up to 40 early-stage drug-development companies over the next eight years. FutuRx offers a unique private-public partnership to reduce risk in investing in breakthrough science. The Israeli governments support of risky projects was a key factor in attracting the partners. The accelerator provides fully equipped labs and support services to startups, with the expectation that they will be able to raise money from the private sector after the incubator term. FutuRx has already chosen two startups to support and plans to approve up to six more projects in the coming months.","partners":["OrbiMed Israel Partners","Johnson & Johnson","Takeda Ventures"],"customers":null,"investors":["OrbiMed Israel Partners","Johnson & Johnson","Takeda Ventures"],"confidence":8,"key_topics":["biotechnology accelerator","early-stage drug-development companies","private-public partnership","pharmaceutical companies","risk reduction"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Investment","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"TDI41NLPjUk8pl4jlN1pNAlChkx0BEetADLRfQcNSLbsWErQSYijRb","news_summary":"Israel takes a risk on tomorrow's epic drugs","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":7,"mediagallery":[],"biverification":"Jenny Sotnik-Talisman","sectorverify":null,"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgMHXnNsIDA","fullname":"Jenny Sotnik-Talisman"},"biverifydate":"2020-01-19T00:00:00.000Z","crunchbaseid":"futurx","lastupdator":"Ortal Wein","lastupdator_email":"ortalw@sncentral.org","creator":null,"creator_email":null,"createdate":"2016-01-04T00:00:00.000Z","recentupdates":[{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-07-18 14:06:54.000000","last_name":"Perlov","first_name":"Maor"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:19:07.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:15:49.000000","last_name":"Wein","first_name":"Ortal"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:01:11.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:05:47.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:01:17.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:17:23.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:18:57.000000","last_name":"Wein","first_name":"Ortal"},{"email":"matane@sncentral.org","source":"Automatic","datetime":"2024-09-16 21:01:19.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:23:19.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:16:19.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:16:31.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:12:01.000000","last_name":"Wein","first_name":"Ortal"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:17:21.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-22 14:26:37.000000","last_name":"Perlov","first_name":"Maor"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:12:37.000000","last_name":"Wein","first_name":"Ortal"},{"email":"matane@sncentral.org","source":"Automatic","datetime":"2025-01-30 10:19:23.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Automatic","datetime":"2024-09-16 21:01:19.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:01:11.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:20:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:16:31.000000","last_name":"Wein","first_name":"Ortal"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:01:11.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:17:21.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-22 14:26:37.000000","last_name":"Perlov","first_name":"Maor"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:12:37.000000","last_name":"Wein","first_name":"Ortal"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:01:11.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:20:04.000000","last_name":"Wein","first_name":"Ortal"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:17:23.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:01:16.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-07-18 14:06:33.000000","last_name":"Perlov","first_name":"Maor"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:19:07.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:20:04.000000","last_name":"Wein","first_name":"Ortal"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-22 14:26:41.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-22 14:26:37.000000","last_name":"Perlov","first_name":"Maor"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:20:13.000000","last_name":"Wein","first_name":"Ortal"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-07-18 14:06:33.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-22 14:26:41.000000","last_name":"Perlov","first_name":"Maor"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:05:47.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:15:49.000000","last_name":"Wein","first_name":"Ortal"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-07-18 14:06:54.000000","last_name":"Perlov","first_name":"Maor"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-01-06 14:45:45.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-01-06 14:47:37.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-01-06 14:47:37.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-01-06 14:45:29.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-01-06 14:45:29.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-01-06 14:43:39.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2022-05-29 12:04:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2022-05-29 12:07:06.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2022-05-29 12:08:20.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2022-05-29 12:06:02.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2022-05-29 12:05:18.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2022-05-29 12:03:47.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2022-05-29 12:07:55.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2022-05-29 12:07:30.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-11-08 13:53:09.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-01-06 07:48:13.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-01-06 07:49:39.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-01-06 07:43:51.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-01-06 07:47:50.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-03-06 14:55:15.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-03-06 14:57:28.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-03-06 14:57:45.000000","last_name":"Maman","first_name":"Yotam"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2018-08-08 17:03:08.000000","last_name":"McCandless","first_name":"Katie"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2018-08-08 17:03:08.000000","last_name":"McCandless","first_name":"Katie"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-10-07 08:13:54.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-01-06 07:42:31.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-01-06 07:47:10.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-01-06 07:40:52.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-01-06 07:45:26.000000","last_name":"Maman","first_name":"Yotam"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2018-04-18 04:46:52.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"idit.rech@gmail.com","source":"Manual","datetime":"2018-01-14 13:47:50.000000","last_name":"Benudiz","first_name":"Idit"},{"email":"idit.rech@gmail.com","source":"Manual","datetime":"2018-01-14 13:52:06.000000","last_name":"Benudiz","first_name":"Idit"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-05-06 06:50:30.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-03-06 14:55:36.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-03-06 14:59:27.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-03-06 14:59:05.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-03-06 14:57:39.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-03-06 14:53:55.000000","last_name":"Maman","first_name":"Yotam"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-01-02 06:28:21.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-01-02 06:28:21.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-01-02 06:28:21.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-01-02 06:28:21.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-01-02 06:28:24.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"ngolczar@gmail.com","source":"Manual","datetime":"2018-01-02 06:28:11.000000","last_name":"Golczar","first_name":"Natalia"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-01-06 07:41:50.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-01-06 07:37:43.000000","last_name":"Maman","first_name":"Yotam"},{"email":"katie.mccandless@gmail.com","source":"Manual","datetime":"2018-08-28 12:59:22.000000","last_name":"McCandless","first_name":"Katie"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2018-10-14 09:43:14.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2018-10-29 15:00:13.000000","last_name":"Maman","first_name":"Yotam"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2018-09-05 09:23:36.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2018-09-05 09:23:57.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"lanternhousecopyediting@gmail.com","source":"Manual","datetime":"2017-01-17 19:40:02.000000","last_name":"Nielsen","first_name":"L."},{"email":"lanternhousecopyediting@gmail.com","source":"Manual","datetime":"2017-01-17 19:40:02.000000","last_name":"Nielsen","first_name":"L."},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-11-23 13:34:49.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2016-11-23 13:48:33.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2017-04-30 08:52:08.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2017-04-30 08:48:42.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2017-04-30 09:03:12.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2017-04-30 09:03:12.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2017-04-30 09:03:12.000000","last_name":"Yaron","first_name":"Ben"},{"email":"benyaron@gmail.com","source":"Manual","datetime":"2017-04-30 08:58:54.000000","last_name":"Yaron","first_name":"Ben"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2017-05-19 05:11:09.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2020-12-20 12:04:57.000000","last_name":"Perlov","first_name":"Maor"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-07-28 15:12:55.000000","last_name":"Maman","first_name":"Yotam"},{"email":"maorperlov@gmail.com","source":"Manual","datetime":"2020-12-20 12:04:33.000000","last_name":"Perlov","first_name":"Maor"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-06-17 09:26:56.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-19 12:54:07.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-02-21 12:18:01.000000","last_name":"Maman","first_name":"Yotam"},{"email":"genys30@yahoo.com","source":"Manual","datetime":"2019-04-09 04:33:14.000000","last_name":"Sotnik-Talisman","first_name":"Jenny"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-12-07 06:48:38.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-12-07 06:48:38.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-12-07 06:48:38.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-19 12:45:02.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-19 12:45:02.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-19 12:55:53.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-19 13:01:39.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-19 12:51:01.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-06-05 13:26:04.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-09-08 11:03:23.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-07-28 06:14:32.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-12-07 06:48:51.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-19 12:56:20.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2020-01-19 12:57:15.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2021-01-24 08:12:12.000000","last_name":"Maman","first_name":"Yotam"},{"email":"yotamm1988@gmail.com","source":"Manual","datetime":"2019-11-05 07:50:01.000000","last_name":"Maman","first_name":"Yotam"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-22 14:26:41.000000","last_name":"Perlov","first_name":"Maor"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:09:57.000000","last_name":"Wein","first_name":"Ortal"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:01:14.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:12:32.000000","last_name":"Wein","first_name":"Ortal"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:14:04.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2024-01-29 17:51:31.000000","last_name":"Wein","first_name":"Ortal"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:17:22.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Automatic","datetime":"2025-01-30 10:19:23.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Automatic","datetime":"2025-01-30 10:19:23.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:12:29.000000","last_name":"Wein","first_name":"Ortal"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:17:22.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Automatic","datetime":"2024-08-12 20:03:03.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:01:16.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:18:57.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:09:50.000000","last_name":"Wein","first_name":"Ortal"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:23:19.000000","last_name":"Wein","first_name":"Ortal"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-22 14:26:37.000000","last_name":"Perlov","first_name":"Maor"},{"email":"ortalw@sncentral.org","source":"Manual","datetime":"2022-10-25 09:16:19.000000","last_name":"Wein","first_name":"Ortal"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:01:14.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-22 14:26:41.000000","last_name":"Perlov","first_name":"Maor"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2023-07-18 14:06:33.000000","last_name":"Perlov","first_name":"Maor"},{"email":"matane@sncentral.org","source":"Manual","datetime":"2024-09-16 21:01:17.000000","last_name":"Eblagon","first_name":"Matan"},{"email":"maor.perlov@sncentral.org","source":"Manual","datetime":"2022-08-22 14:26:37.000000","last_name":"Perlov","first_name":"Maor"}],"rounds_per_sector":[{"count":24,"sector":"Health Tech & Life Sciences"}],"rounds_per_stage":[{"count":1,"isfollowon":0,"fundingStage":"Pre-Seed"},{"count":15,"isfollowon":0,"fundingStage":"Seed"},{"count":8,"isfollowon":0,"fundingStage":"Undisclosed"}],"investment_rounds_over_time":[{"year":2015,"month":1,"record_count":1},{"year":2015,"month":12,"record_count":1},{"year":2016,"month":7,"record_count":1},{"year":2016,"month":8,"record_count":1},{"year":2017,"month":1,"record_count":1},{"year":2017,"month":5,"record_count":3},{"year":2018,"month":9,"record_count":2},{"year":2018,"month":10,"record_count":1},{"year":2019,"month":1,"record_count":3},{"year":2019,"month":2,"record_count":1},{"year":2019,"month":11,"record_count":2},{"year":2020,"month":5,"record_count":1},{"year":2020,"month":9,"record_count":1},{"year":2020,"month":10,"record_count":1},{"year":2020,"month":11,"record_count":1},{"year":2021,"month":5,"record_count":1},{"year":2021,"month":12,"record_count":1},{"year":2022,"month":9,"record_count":1}],"portfolio_companies_per_sector":[{"count":24,"sector":"Health Tech & Life Sciences"}],"new_portfolio_companies_over_time":[{"year":2015,"month":1,"record_count":1},{"year":2015,"month":12,"record_count":1},{"year":2016,"month":7,"record_count":1},{"year":2016,"month":8,"record_count":1},{"year":2017,"month":1,"record_count":1},{"year":2017,"month":5,"record_count":3},{"year":2018,"month":9,"record_count":2},{"year":2018,"month":10,"record_count":1},{"year":2019,"month":1,"record_count":3},{"year":2019,"month":2,"record_count":1},{"year":2019,"month":11,"record_count":2},{"year":2020,"month":5,"record_count":1},{"year":2020,"month":9,"record_count":1},{"year":2020,"month":10,"record_count":1},{"year":2020,"month":11,"record_count":1},{"year":2021,"month":5,"record_count":1},{"year":2021,"month":12,"record_count":1},{"year":2022,"month":9,"record_count":1}],"exits_over_time":[{"year":2024,"count":1,"eventType":"MNAEvent"},{"year":2019,"count":1,"eventType":"ReverseMergerEvent"}],"exits_by_sector":[{"count":2,"sector":"Health Tech & Life Sciences"}],"affiliatedOrganizations":[{"id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAwISPx9ELDA","name":"Johnson & Johnson","type":"Multinational","hidden":false,"fullurl":"/mnc_page/johnson-johnson","logokey":"$ZGZLV7DUlFkgUtW3RRol27Vr6RIBnPlja5TeXVQC7G3Ey1ZR0rrMIS.jpeg","logourl":"https://storage.googleapis.com/clean-finder-353810/$ZGZLV7DUlFkgUtW3RRol27Vr6RIBnPlja5TeXVQC7G3Ey1ZR0rrMIS.jpeg","onClick":"","visibilityClassName":"","visibilityTooltip":""}],"timeline":[],"databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Incubator","parsedName":"FutuRx","logourl":"https://storage.googleapis.com/clean-finder-353810/$XxQiFrU4R30LKDcmXaXZVedqfornovhC31j8y0EG4TthCyoN21hBrd","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$XxQiFrU4R30LKDcmXaXZVedqfornovhC31j8y0EG4TthCyoN21hBrd","teamMembersNumber":5,"section":null,"sectionParams":"","queryParams":"","seoabout":"FutuRx was founded by Johnson & Johnson Innovation – JJDC, Takeda Pharmaceutical Company, through its venture group Takeda Ventures Inc.-TVI and OrbiMed Is...","seoTitle":"Israeli Incubator","serializedCharts":"{\"investmentsRoundsByRoundType\":[{\"fundingStage\":\"Pre-Seed\",\"newInvestments\":1,\"followOnInvestments\":0},{\"fundingStage\":\"Seed\",\"newInvestments\":15,\"followOnInvestments\":0},{\"fundingStage\":\"Undisclosed\",\"newInvestments\":8,\"followOnInvestments\":0}],\"investmentRoundsBySector\":[{\"count\":24,\"sector\":\"Health Tech & Life Sciences\"}],\"investmentRoundsOverTime\":[{\"label\":\"2015\",\"count\":2},{\"label\":\"2016\",\"count\":2},{\"label\":\"2017\",\"count\":4},{\"label\":\"2018\",\"count\":3},{\"label\":\"2019\",\"count\":6},{\"label\":\"2020\",\"count\":4},{\"label\":\"2021\",\"count\":2},{\"label\":\"2022\",\"count\":1},{\"label\":\"2023\",\"count\":0},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"portfolioCompaniesBySector\":[{\"count\":24,\"sector\":\"Health Tech & Life Sciences\"}],\"portfolioCompaniesOverTime\":[{\"label\":\"2015\",\"count\":2},{\"label\":\"2016\",\"count\":2},{\"label\":\"2017\",\"count\":4},{\"label\":\"2018\",\"count\":3},{\"label\":\"2019\",\"count\":6},{\"label\":\"2020\",\"count\":4},{\"label\":\"2021\",\"count\":2},{\"label\":\"2022\",\"count\":1},{\"label\":\"2023\",\"count\":0},{\"label\":\"2024\",\"count\":0},{\"label\":\"2025\",\"count\":0},{\"label\":\"2026\",\"count\":0}],\"exitsOverTime\":[{\"year\":2024,\"count\":1,\"eventType\":\"MNAEvent\"},{\"year\":2019,\"count\":1,\"eventType\":\"ReverseMergerEvent\"},{\"year\":2015,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2015,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2016,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2016,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2017,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2017,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2018,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2018,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2020,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2020,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2021,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2021,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2022,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2022,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2023,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2023,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2025,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2025,\"count\":0,\"eventType\":\"publicExits\"},{\"year\":2026,\"count\":0,\"eventType\":\"MNAEvent\"},{\"year\":2026,\"count\":0,\"eventType\":\"publicExits\"}],\"exitsBySector\":[{\"count\":2,\"sector\":\"Health Tech & Life Sciences\"}]}","statusinfo":"","iiasupport":"Previously Supported By","managedAssetsNumber":null,"investmentrange":"$2.7M - $3.6M","communityinvolvement":[],"foreignInvestments":"","nationality":"Israeli","investorStatistics":{"exitRatio":{"amount":"0"},"investmentFollowOnRatio":{"amount":""},"leadInvestorShare":{"amount":"0"},"soloInvestmentRoundRatio":{"amount":"0"},"firstInvestorRatio":{"amount":"0"}},"popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none"},"mainContact":{}}